Radioimmunotherapy Combined with Maintenance Anti-CD20 Antibody May Trigger Long-Term Protective T Cell Immunity in Follicular Lymphoma Patients

Growing evidence suggests that the patient’s immune response may play a major role in the long-term efficacy of antibody therapies of follicular lymphoma (FL). Particular long-lasting recurrence free survivals have been observed after first line, single agent rituximab or after radioimmunotherapy (R...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Franz Buchegger, Steven M. Larson, Jean-Pierre Mach, Yves Chalandon, Pierre-Yves Dietrich, Anne Cairoli, John O. Prior, Pedro Romero, Daniel E. Speiser
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2013-01-01
coleção:	Clinical and Developmental Immunology
Acesso em linha:	http://dx.doi.org/10.1155/2013/875343
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!